This Week in NEJM | GenomeWeb

This Week in NEJM

Premium

In NEJM this week, an international team led by the University of Turin's Antonio Palumbo reports on the efficacy of continuous lenalidomide treatment for patients with newly diagnosed multiple myeloma. The team randomly assigned 459 patients who were ineligible for transplantation to receive either melphalan-prednisone-lenalidomide induction followed by lenalidomide maintenance therapy, melphalan-prednisone-lenalidomide without maintenance therapy, or melphalan-prednisone without maintenance therapy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.